Study Completed

Erectile Dysfunction

Bayer Identifier:

12709

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2007-006649-42

EU CT Number:

Not Available

BAY38-9456 ER prototype anionic polymer fed vs fasting

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

18 - 50 Years

Trial summary

Enrollment Goal

Trial Dates

January 2008 - March 2008

Phase

Phase 1

Could I Receive a placebo

N/A

Products

Vardenafil ER (BAY38-9456)

Accepts Healthy Volunteer

N/A

Where to participate

Status	Institution	Location
Completed	MEDA Manufacturing GmbH, ClinPharmCologne	Köln, 51063, Germany

Trial design

Randomized study in a 3-fold crossover, single-dose design to investigate the pharmacokinetics of a 20 mg vardenafil extended release tablet formulation in the fed and fasted condition, respectively, in comparison to a 20 mg standard Levitra® tablet in healthy male subjects

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.